发明名称 METHOD FOR THE PRODUCTION OF RECOMBINANT VIRUS, DNA CONSTRUCTS, RECOMBINANT VIRUS AND VACCINE COMPOSITIONS
摘要 The purpose of the present invention is the production of recombinant virus through the cloning and expression of sequences of coding nucleotides of the whole or part of heterolog proteins, through the following method: (a) modification of the heterolog nucleotides sequences in such way they when cloned and expressed in the vector virus, the present in the 5′ region nucleotides present in the 5′ edge of the gene NS1 of this vector virus or of other virus or equivalent functional sequences, and in its 3′ region, the correspondent genome region in the whole or part of the spheres of the steam and anchor of the protein E of this vector virus or equivalent functional sequences, and not comprising the structure and the replication of the mention vector virus; (b) insertion of the modified heterolog sequences in (a) in the intergene region at the structural protein E level and of nonstructural NS1 vector virus; (c) obtention of the non pathogenic recombinant virus and owner of the immunologic properties, having the heterolog sequences integrated in the viral genome according to the insertion described in (b) and, like that, expressing the heterolog antigene in such way that it can induce an appropriate immune response. The present invention is also addressed to vaccine compositions to immune against the Flavivirus and/or other pathogens.
申请公布号 US2015024003(A1) 申请公布日期 2015.01.22
申请号 US201414304387 申请日期 2014.06.13
申请人 Bonaldo Myrna Cristina;Galler Ricardo 发明人 Bonaldo Myrna Cristina;Galler Ricardo
分类号 A61K39/12 主分类号 A61K39/12
代理机构 代理人
主权项 1. A recombinant vaccine virus comprising nucleotide sequences encoding at least one heterologous protein, or fragments thereof, wherein said vector virus sequence comprises nucleotide sequences encoding the NS1 protein and the E protein sequence of a Flavivirus; further wherein the heterologous sequence is inserted in the E/NS1 intergenic region, further wherein the nucleotides present at the 5′ end of the NS1 gene and the whole or part of the domains of stem and anchor of the E protein are present at either end of the heterologous sequence; and wherein when the heterologous protein is expressed it will be processed normally by a host cell and can induce an immune response.
地址 Rio de Janeiro BR